Is Aethlon Medical Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: AEMD) stock is to Buy AEMD stock.
Out of 1 analyst, 0 (0%) are recommending AEMD as a Strong Buy, 1 (100%) are recommending AEMD as a Buy, 0 (0%) are recommending AEMD as a Hold, 0 (0%) are recommending AEMD as a Sell, and 0 (0%) are recommending AEMD as a Strong Sell.
What is AEMD's earnings growth forecast for 2026-2026?
(NASDAQ: AEMD) Aethlon Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.
Aethlon Medical's earnings in 2025 is -$9,558,614.
In 2026, AEMD is forecast to generate -$7,083,977 in earnings, with the lowest earnings forecast at -$7,083,977 and the highest earnings forecast at -$7,083,977.
What is AEMD's forecast return on equity (ROE) for 2026-2027?
(NASDAQ: AEMD) forecast ROE is N/A, which is considered weak.
What is AEMD's Price Target?
According to 1 Wall Street analyst that have issued a 1 year AEMD price target, the average AEMD price target is $7.00, with the highest AEMD stock price forecast at $7.00 and the lowest AEMD stock price forecast at $7.00.
The Wall Street analyst predicted that Aethlon Medical's share price could reach $7.00 by Mar 10, 2026. The average Aethlon Medical stock price prediction forecasts a potential upside of 2,027.66% from the current AEMD share price of $0.33.
What is AEMD's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: AEMD) Aethlon Medical's current Earnings Per Share (EPS) is -$1.58. In 2026, AEMD's EPS is forecast to hit -$0.49 (min: -$0.49, max: -$0.49).
What is AEMD's forecast return on assets (ROA) for 2026-2027?
(NASDAQ: AEMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.